Page last updated: 2024-10-22

amifostine anhydrous and Spider Veins

amifostine anhydrous has been researched along with Spider Veins in 1 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Research Excerpts

ExcerptRelevanceReference
"Twenty-nine patients with localized prostate cancer were accrued."1.31A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury. ( Ben-Josef, E; Biggar, S; Bonner, HS; Han, S; Kaplan, I; Kelly, L; Prokop, S; Shaw, LM; Stamos, B; Tobi, M; Vargas, BJ, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ben-Josef, E1
Han, S1
Tobi, M1
Shaw, LM1
Bonner, HS1
Vargas, BJ1
Prokop, S1
Stamos, B1
Kelly, L1
Biggar, S1
Kaplan, I1

Other Studies

1 other study available for amifostine anhydrous and Spider Veins

ArticleYear
A pilot study of topical intrarectal application of amifostine for prevention of late radiation rectal injury.
    International journal of radiation oncology, biology, physics, 2002, Aug-01, Volume: 53, Issue:5

    Topics: Adenocarcinoma; Administration, Topical; Amifostine; Analysis of Variance; Dose-Response Relationshi

2002